Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
12/20/2012 | WO2012174289A2 A novel fluorescence-based assay for the rapid detection and quantification of deoxyribonucleoside triphosphates |
12/20/2012 | WO2012174282A2 Biomarker compositions and methods |
12/20/2012 | WO2012174256A2 Dna methylation profiles in cancer |
12/20/2012 | WO2012174225A2 Isolation, expansion and use of autologous pluripotent stem cells |
12/20/2012 | WO2012174214A1 High resolution analysis of mammalian transcriptome using gene pool specific primers |
12/20/2012 | WO2012174203A2 Methods and kits for the detection and treatment of recurring prostate cancer |
12/20/2012 | WO2012174192A2 Method of amplifying a nucleic acid |
12/20/2012 | WO2012174187A2 Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
12/20/2012 | WO2012174142A1 Flat-field imaging system and methods of use |
12/20/2012 | WO2012174129A1 Biomarkers for necrotizing enterocolitis and sepsis |
12/20/2012 | WO2012174119A2 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains |
12/20/2012 | WO2012174112A2 Systems and methods for an optical nanoscale array for sensing and recording of electrically excitable cells |
12/20/2012 | WO2012173994A2 Phase changing formulations of nucleic acid payloads |
12/20/2012 | WO2012173919A1 Method of processing a sample for analysis |
12/20/2012 | WO2012173905A1 Salt-tolerant dna polymerases |
12/20/2012 | WO2012173866A2 Methods of identifying an organism |
12/20/2012 | WO2012173809A2 Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders |
12/20/2012 | WO2012173636A1 Hiv incidence assays with high sensitivity and specificity |
12/20/2012 | WO2012173358A2 Testis somatic cell-derived pluripotent stem cells, method for producing same, and pharmaceutical composition for impotence treatment including same |
12/20/2012 | WO2012173274A1 Nucleic acid probe for assaying nucleic acids |
12/20/2012 | WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals |
12/20/2012 | WO2012173185A1 Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit |
12/20/2012 | WO2012173015A1 Probe set and use thereof |
12/20/2012 | WO2012172575A1 Genetic variants for predicting risk of breast cancer |
12/20/2012 | WO2012172555A1 Combination therapy to prevent dcis formation and progression to breast cancer |
12/20/2012 | WO2012172546A1 Target-recognition compositions comprising novel synthetic conjugates for trapping and diagnosis of a target molecule |
12/20/2012 | WO2012172511A1 Method for the prognosis of breast cancer based on the expression of the gene pin1 in combination with mutations in the gene tp53 |
12/20/2012 | WO2012172221A2 Molecular signature of pigment spots on the skin, associated with extracellular matrix organization |
12/20/2012 | WO2012172220A1 Molecular signature for skin pigment spots, which is combined with the extracellular matrix |
12/20/2012 | WO2012171997A1 Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals |
12/20/2012 | WO2012171990A1 Discrimination of blood type variants |
12/20/2012 | WO2012171949A2 Thromboembolic disease |
12/20/2012 | WO2012171922A1 Diagnostic device |
12/20/2012 | WO2012171920A1 Treatment device |
12/20/2012 | WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell |
12/20/2012 | WO2012171213A1 Method and system for assembly of genome |
12/20/2012 | WO2012171127A1 Automated size selection of nucleic acids |
12/20/2012 | WO2012171112A1 Isolated embryonic stem cells that express lineage markers and associated methods |
12/20/2012 | WO2012149193A3 Diagnostic molecular markers for seed lot purity traits in soybeans |
12/20/2012 | WO2012138740A3 Risk analysis for disease development |
12/20/2012 | WO2012135340A3 Compositions and methods for diagnosing cancer |
12/20/2012 | WO2012135053A3 Rnase h-based assays utilizing modified rna monomers |
12/20/2012 | WO2012130720A3 PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS |
12/20/2012 | WO2012121486A3 Gene analysis method using sdl-pcr |
12/20/2012 | WO2012120374A3 Methods and biomarkers for detection of gastrointestinal cancers |
12/20/2012 | WO2012115493A3 Biomarker for cancer, and cancer diagnosis using same |
12/20/2012 | WO2012115464A3 Composition for hot-start pcr comprising blocking oligonucleotide |
12/20/2012 | WO2012115454A3 Method for concentrating cells that are genetically altered by nucleases |
12/20/2012 | WO2012112012A3 Simultaneous diagnosis kit for a disease due to a respiratory virus |
12/20/2012 | WO2012109574A3 Assay methods using dna binding proteins |
12/20/2012 | WO2012108706A3 Kit for diagnosing tamiflu-sensitive and resistant novel influenza a (h1n1) simultaneously and diagnosis method using same |
12/20/2012 | WO2012108675A3 Pna aptamer able to isolate a metal |
12/20/2012 | WO2012108669A3 Uranyl ion specific dna aptamer |
12/20/2012 | WO2012102584A3 Sensor for detecting target virus, and method for screening target virus and analyzing mutation location using same |
12/20/2012 | WO2012102527A3 Novel use of regulatory t cell-specific surface protein lrig-1 |
12/20/2012 | WO2012065043A9 Classification of nucleic acid templates |
12/20/2012 | WO2012058638A3 Nucleic acid nanostructure barcode probes |
12/20/2012 | WO2007012811A9 Prostate stem cell markers |
12/20/2012 | US20120324603 Chimeric Endonucleases and Uses Thereof |
12/20/2012 | US20120324599 Methods and Compositions for Gray Leaf Spot Resistance in Corn |
12/20/2012 | US20120324598 Genetic loci associated with fusarium solani tolerance in soybean |
12/20/2012 | US20120324593 Lysyl Oxidase-Like 1 (LOXL1) and Elastogenesis |
12/20/2012 | US20120322865 Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
12/20/2012 | US20120322847 ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
12/20/2012 | US20120322792 Method and Compositions for Treating Cancer and Related Methods |
12/20/2012 | US20120322743 Compositions and Methods for Diagnosing and Treating Melanoma |
12/20/2012 | US20120322717 Compounds and assays for controlling Wnt activity |
12/20/2012 | US20120322689 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
12/20/2012 | US20120322688 Testing lumenectomy samples for markers of non-vascular diseases |
12/20/2012 | US20120322687 Methods of predicting high grade gliomas using senescence associated genes |
12/20/2012 | US20120322685 Device for collecting and analyzing migratory tumor cells |
12/20/2012 | US20120322684 G-csf protein having a deletion of an amino acid sequence corresponding to exon 3 for use as a diagnostic cancer marker |
12/20/2012 | US20120322683 Enzymatic signal generation and detection of binding complexes in stationary fluidic chip |
12/20/2012 | US20120322676 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains |
12/20/2012 | US20120322674 Detecting cyp24 expression level as a marker for predisposition to cancer |
12/20/2012 | US20120322673 Isolation of nucleic acid from mouth epithelial cells |
12/20/2012 | US20120322670 Identifying genetic variation in affected tissues |
12/20/2012 | US20120322669 Methods of marking materials |
12/20/2012 | US20120322668 Assessment of solid tumor burden |
12/20/2012 | US20120322667 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
12/20/2012 | US20120322666 Isolation of polymerase-nucleic acid complexes |
12/20/2012 | US20120322146 Neural cell populations from primate pluripotent stem cells |
12/20/2012 | US20120322113 Nucleic acid amplification |
12/20/2012 | US20120322112 Crude biological derivatives competent for nucleic acid detection |
12/20/2012 | US20120322109 Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccinia Topoisomerase |
12/20/2012 | US20120322098 Culture medium for screening or enrichment of methicillin-resistant s. aureus |
12/20/2012 | US20120322097 Device and method for culturing cells in a biomimetic environment |
12/20/2012 | US20120322094 High-molecular-weight adiponectin measurement method |
12/20/2012 | US20120322092 Resonance Energy Transfer Assay with Synaptobrevin Substrate Moiety |
12/20/2012 | US20120322091 Pharmacologic method of lowering cholesterol production |
12/20/2012 | US20120322079 Method for testing or screening protein synthesis inhibitors |
12/20/2012 | US20120322078 Production of Propanols, Alcohols, and Polyols in Consolidated Bioprocessing Organisms |
12/20/2012 | US20120322075 Lung Tumor Markers and Methods of Use Thereof |
12/20/2012 | US20120322074 Prostate Tumor Markers and Methods of Use Thereof |
12/20/2012 | US20120322073 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor |
12/20/2012 | US20120322072 Quantification of a minority nucleic acid species |
12/20/2012 | US20120322071 Method for quantitative measurement of gene expression for indentifying individuals at risk for bronchogenic carcinoma |
12/20/2012 | US20120322070 Cryogenic biopsy system and method |
12/20/2012 | US20120322069 Diagnositic Methods of Tumor Susceptibility With Nucleotide Polymorphisms Inside MicroRNA Target Sites |
12/20/2012 | US20120322068 Method for identifying increased risk of anxiety disorders |